A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer’s Disease by Peptidome Technology-Reference-Cited by-同舟云学术

A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer’s Disease by Peptidome Technology

Published:2020-01-07 Issue:1 Volume:73 Page:217-227
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Abe Koji¹,Shang Jingwei¹,Shi Xiaowen¹,Yamashita Toru¹,Hishikawa Nozomi¹,Takemoto Mami¹,Morihara Ryuta¹,Nakano Yumiko¹,Ohta Yasuyuki¹,Deguchi Kentaro²,Ikeda Masaki³,Ikeda Yoshio³,Okamoto Koichi⁴,Shoji Mikio⁴,Takatama Masamitsu⁴,Kojo Motohisa⁵,Kuroda Takeshi⁶,Ono Kenjiro⁶,Kimura Noriyuki⁷,Matsubara Etsuro⁷,Osakada Yosuke⁸,Wakutani Yosuke⁸,Takao Yoshiki⁸,Higashi Yasuto⁹,Asada Kyoichi¹⁰,Senga Takehito¹⁰,Lee Lyang-Ja¹⁰,Tanaka Kenji¹⁰

Affiliation:

1. Department of Neurology, Okayama University, Okayama, Japan

2. Department of Neurology, Okayama City Hospital, Okayama, Japan

3. Department of Neurology, Gunma University, Graduate School of Medicine, Maebashi, Japan

4. Department of Neurology, Geriatrics Research Institute and Hospital, Maebashi, Japan

5. Department of Neurology, Ako Chuo Hospital, Ako, Japan

6. Division of Neurology, Department of Medicine, Showa University, School of Medicine, Tokyo, Japan

7. Department of Neurology, Faculty of Medicine, Oita University, Oita, Japan

8. Department of Neurology, Kurashiki Heisei Hospital, Kurashiki, Japan

9. Department of Neurology, Himeji Central Hospital, Himeji, Japan

10. Membrane Protein and Ligand Analysis Center, Protosera Inc., Osaka, Japan

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference54 articles.

1. Dementia: A problem for our age;Abbott;Nature,2011

2. Characteristic features of cognitive, affective and daily living functions of late-elderly dementia;Hishikawa;Geriatr Gerontol Int,2016

3. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer’s disease: A study in Japan;Kanai;Ann Neurol,1998

4. Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer’s disease model mouse;Takamura;Mol Neurodegener,2011

5. Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer’s disease accelerates β-amyloid-42 assembly;Takamura;J Neurosci Res,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease by Selected Reaction Monitoring;Journal of Alzheimer's Disease;2024-06-25

2. Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer’s Disease Combined with Cerebral Hypoperfusion;Journal of Alzheimer's Disease;2023-11-07

3. COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved;Current Medicinal Chemistry;2023-10

4. Peptidomic Approaches and Observations in Neurodegenerative Diseases;International Journal of Molecular Sciences;2022-06-30

5. Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview;Cells;2022-04-17